Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.
Also called NCT02617069
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 170 participants
- Registry
-
NCT02617069
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT02617069. Randomized; double masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2016-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery
- Condition
- Atrial Fibrillation
- Intervention (Biological)
- botulinum toxin injection
- Intervention (Biological)
- 0.9% normal saline injection
- Intervention (Device)
- Implantable loop recorder
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
Record details
- Record id
cardio:ct-nct02617069- Content hash
9e1f2a2ae647be17c08e2239fc3cf7bf6457d2396bb2276ae819c11d09973cec